# Boehringer Ingelheim invests €100M in Respimat production plant in Barcelona

Boehringer Ingelheim held a groundbreaking ceremony for a new production plant in Sant Cugat del Vallès, Barcelona, to manufacture the Respimat inhaler device. The investment exceeds €100 million and will create over 200 jobs, with annual production of 25 million units.

- Type: New facility
- Announced: 2017-06-27
- Where: Sant Cugat del Vallès, Barcelona, Spain
- Value: $112.0M (100.0M EUR)
- Jobs: 200
- Status: under construction
- Capacity: 25 million units per year
- Products: Respimat inhaler device
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Boehringer Ingelheim](https://endata.com/companies/25171.md)

## Sources

- [pharmatech.es](https://www.pharmatech.es/noticias/20170627/boehringer-invertira-100-millones-produccion-respimat-barcelona), 2017-06-27: "Es una oportunidad para crear más de 200 nuevos puestos de trabajo altamente cualificados y llevar a cabo una inversión de más de 100 millones de euros."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.